Drug-induced neurobehavioral plasticity: The role of environmental context

Behavioural Pharmacology

Volumn 15, Issue 5-6, 2004, Pages 327-339

  Badiani, A ^a   Robinson, T E ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Addiction; Context; Dendrites; Dendritic spines; Environment; Immediate early genes; Learning; Novelty; Opioids; Plasticity; Psychostimulants; Sensitization; Stress

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE; MORPHINE; PSYCHOSTIMULANT AGENT;

BEHAVIOR; BRAIN REGION; DOPAMINERGIC TRANSMISSION; DRUG DISCRIMINATION; DRUG EFFECT; DRUG REEXPOSURE; DRUG SENSITIZATION; ENVIRONMENTAL FACTOR; GENE EXPRESSION; HUMAN; HYPERACTIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMEDIATE EARLY GENE; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; ONCOGENE C FOS; PSYCHOMOTOR ACTIVITY; REVIEW; STATE DEPENDENT LEARNING;

EID: 4544243657     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200409000-00004     Document Type: Review

References (146)

1. Alheid GF, Heimer L (1988). New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience 27:1-39.
2. Altier N, Stewart J (1999). The role of dopamine in the nucleus accumbens in analgesia. Life Sci 65:2269-2287.
3. Anagnostaras SG, Robinson TE (1996). Sensitization to the psychomotor stimulant effects of amphetamine: modulation by associative learning. Behav Neurosci 110:1397-1414.
4. Anagnostaras SG, Schallert T, Robinson TE (2002). Memory processes governing amphetamine-induced psychomotor sensitization. Neuropsychopharmacology 26:703-715.
5. Anisman H, Hahn B, Hoffman D, Zacharko RM (1985). Stressor invoked exacerbation of amphetamine-elicited perseveration. Pharmacol Biochem Behav 23:173-183.
6. Antelman SM, Eichler AJ, Black CA, Kocan D (1980). Interchangeability of stress and amphetamine in sensitization. Science 207:329-331.
7. Badiani A, Anagnostaras SG, Robinson TE (1995a). The development of sensitization to the psychomotor stimulant effects of amphetamine is enhanced in a novel environment. Psychopharmacology (Berl) 117:443-452.
8. Badiani A, Browman KE, Robinson TE (1995b). Influence of novel versus home environments on sensitization to the psychomotor stimulant effects of cocaine and amphetamine. Brain Res 674:291-298.
9. Badiani A, Morano I, Akil H, Robinson TE (1995c). Circulating adrenal hormones are not necessary for the development of sensitization to the psychomotor activating effects of amphetamine. Brain Res 673:13-24.
10. Badiani A, Leone P, Noel MB, Stewart J (1995d). Ventral tegmental area opioid mechanisms and modulation of ingestive behaviors. Brain Res 670:264-276.
11. Badiani A, Camp DM, Robinson TE (1997). Enduring enhancement of amphetamine sensitization by drug-associated environmental stimuli. J Pharmacol Exp Ther 282:787-794.
12. Badiani A, Oates MM, Day HEW, Watson SJ, Akil H, Robinson TE (1998). Amphetamine-induced behavior, dopamine release and c-fos mRNA expression: modulation by environmental novelty. J Neurosci 18: 10579-10593.
13. Badiani A, Oates MM, Day HEW, Watson SJ, Akil H, Robinson TE (1999). Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behav Brain Res 103:203-209.
14. Badiani A, Oates MM, Fraioli S, Browman KE, Ostrander MM, Xue CJ, et al. (2000a). Environmental modulation of the response to amphetamine: dissociation between changes in behavior and changes in dopamine and glutamate overflow in the rat striatal complex. Psychopharmacology (Berl) 151:166-174.
15. Badiani A, Oates MM, Robinson TE (2000b). Modulation of morphine sensitization in the rat by contextual stimuli. Psychopharmacology (Berl) 151:273-282.
16. Bardo MT, Bowling SL, Rowlett JK, Manderscheid P, Buxton ST, Dwoskin LP (1995). Environmental enrichment attenuates locomotor sensitization, but not in vitro dopamine release, induced by amphetamine. Pharmacol Biochem Behav 51:397-405.
17. Barrett JE (1987). Nonpharmacological factors determining the behavioral effects of drugs. In: Meltzer HY (editor): Psychopharmacology: The Third Generation of Progress. New York: Raven Press; pp. 1493-1501.
18. Bartlett E, Hallin A, Chapman B, Angrist B (1997). Selective sensitization to the psychosis-inducing effects of cocaine: a possible marker for addiction relapse vulnerability? Neuropsychopharmacology 16:77-82.
19. Baumeister AA, Anticich TG, Hawkins MF, Liter JC, Thibodeaux HF, Guillory EC (1988). Evidence that the substantia nigra is a component of the endogenous pain suppression system in the rat. Brain Res 447:116-121.
20. Berretta S, Robertson HA, Graybiel AM (1992). Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J Neurophysiol 68:767-777.
21. Berretta S, Robertson HA, Graybiel AM (1993). Neurochemically specialized projection neurons of the striatum respond differentially to psychomotor stimulants. Prog Brain Res 99:201-205.
22. Berretta S, Parthasarathy HB, Graybiel AM (1997). Local release of GABAergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum. J Neurosci 17:4752-4763.
23. Browman KE, Badiani A, Robinson TE (1998a). Modulatory effect of environmental stimuli on the susceptibility to amphetamine sensitization: a dose-effect study in rats. J Pharmacol Exp Ther 287:1007-1014.
24. Browman KE, Badiani A, Robinson TE (1998b). The influence of environment on the induction of sensitization to the psychomotor activating effects of intravenous cocaine in rats is dose-dependent. Psychopharmacology (Berl) 137:90-98.
25. Cador M, Kelley AE, Le Moal M, Stinus L (1986). Ventral tegmental area infusion of substance P, neurotensin and enkephalin: differential effects on feeding behavior. Neuroscience 18:659-699.
26. Callahan PM, de la Garza R 2nd, Cunningham KA (1997). Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems. Pharmacol Biochem Behav 57:601-607.
27. Cardinal RN, Parkinson JA, Hall J, Everitt BJ (2002). Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 26:321-352.
28. Castner SA, Goldman-Rakic PS (1999). Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys. Neuropsychopharmacology 20:10-28.
29. Castner SA, Goldman-Rakic PS (2003). Amphetamine sensitization of hallucinatory-like behaviors is dependent on prefrontal cortex in nonhuman primates. Biol Psychiatry 54:105-110.
30. Cenci MA, Björklund A (1993). Transection of corticostriatal afferents reduces amphetamine- and apomorphine-induced striatal Fos expression and turning behavior in unilaterally 6-hydroxydopamine-lesioned rats. Eur J Neurosci 5:1062-1070.
31. Chang SL, Squinto SP, Harlan RE (1988). Morphine activation of c-fos expression in rat brain. Biochem Biophys Res Commun 157:698-704.
32. Chappell PB, Smith MA, Kilts CD, Bissette G, Ritchie J, Anderson C, Nemeroff CB (1986). Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 6:2908-2914.
33. Colpaert FC (1995). Drug discrimination: no evidence for tolerance to opiates. Pharmacol Rev 47:605-629.
34. Crombag HS, Badiani A, Robinson TE (1996). Signalled versus unsignalled intravenous amphetamine: large differences in the acute psychomotor response and sensitization. Brain Res 722:227-231.
35. Crombag HS, Badiani A, Maren S, Robinson TE (2000). The role of contextual versus discrete drug-associated cues in promoting the induction of psychomotor sensitization to intravenous amphetamine. Behav Brain Res 116:1-22.
36. Crombag HS, Badiani A, Chan J, Dell'Orco J, Dineen SP, Robinson TE (2001). The ability of environmental context to facilitate psychomotor sensitization to amphetamine can be dissociated from its effect on acute drug responsiveness and on conditioned responding. Neuropsychopharmacology 24: 680-690.
37. Cullinan WE, Herman JP, Battaglia DF, Akil H, Watson SJ (1995). Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience 64:477-505.
38. Day HEW, Badiani A, Uslaner JM, Oates MM, Vittoz NM, Robinson TE, et al. (2001). Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala. J Neurosci 21:732-740.
39. Day HEW, Vittoz NM, Oates MM, Badiani A, Watson SJ Jr, Robinson TE, Akil H (2002). A 6-hydroxydopamine lesion of the mesostriatal dopamine system decreases the expression of corticotropin releasing hormone and neurotensin mRNAs in the amygdala and bed nucleus of the stria terminalis. Brain Res 945:151-159.
40. D'Costa A, Breese CR, Boyd RL, Booze RM, Sonntag WE (1991). Attenuation of Fos-like immunoreactivity induced by a single electroconvulsive shock in brains of aging mice. Brain Res 567:204-211.
41. Di Chiara G, Imperato A (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278.
42. Druhan JP, Fibiger HC, Phillips AG (1990). Amphetamine-like stimulus properties produced by electrical stimulation of reward sites in the ventral tegmental area. Behav Brain Res 38:175-184.
43. Druhan JP, Deschamps SE, Stewart J (1993). D-amphetamine-like stimulus properties are produced by morphine injections into the ventral tegmental area but not into the nucleus accumbens. Behav Brain Res 59:41-51.
44. Everitt BJ, Wolf ME (2002). Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 22:3312-3320.
45. Everitt BJ, Parkinson JA, Olmstead MC, Arroyo M, Robledo P, Robbins TW (1999). Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann NY Acad Sci 877:412-438.
46. Falk JL, Feingold DA (1987). Environmental and cultural factors in the behavioral actions of drugs. In: Meltzer HY (editor): Psychopharmacology: The Third Generation of Progress. New York: Raven Press; pp. 1503-1510.
47. Ferguson SM, Robinson TE (2004). Amphetamine-evoked gene expression in striatopallidal neurons: regulation by corticostriatal afferents and the ERK/MAPK signaling cascade (submitted).
48. Ferguson SM, Norton CS, Watson SJ, Akil H, Robinson TE (2003). Amphetamine-evoked c-fos mRNA expression in the caudate-putamen: the effects of DA and NMDA receptor antagonists vary as a function of neuronal phenotype and environmental context. J Neurochem 86:33-44.
49. Ferguson SM, Thomas MJ, Robinson TE (2004). Morphine-induced c-fos mRNA expression in striatofugal circuits: modulation by dose, environmental context, and drug history. Neuropsychopharmacology (in press).
50. Flores C, Stewart J (2000). Basic fibroblast growth factor as a mediator of the effects of glutamate in the development of long-lasting sensitization to stimulant drugs: studies in the rat. Psychopharmacology (Berl) 151: 152-165.
51. Fraioli S, Crombag HS, Badiani A, Robinson TE (1999). Susceptibility to amphetamine-induced locomotor sensitization is modulated by environmental stimuli. Neuropsychopharmacology 20:533-541.
52. Friedman SB, Ader R (1967). Adrenocortical response to novelty and noxious stimulation, Neuroendocrinology 2:209-212.
53. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612.
54. Graybiel AM, Moratalla R, Robertson HA (1990). Amphetamine and cocaine induce drug specific activation of the c-fos gene in striosome matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci USA 87:6912-6916.
55. Handa RJ, Nunley KM, Bollnow MR (1993). Induction of c-fos mRNA in the brain and anterior pituitary gland by a novel environment. Neuroreport 4: 1079-1082.
56. Harlan RE, Garcia MM (1998). Drugs of abuse and immediate-early genes in the forebrain. Mol Neurobiol 16:221-267.
57. Harmer C, Phillips G (1999). Enhanced dopamine efflux in the amygdala by a predictive, but not a non-predictive, stimulus: facilitation by prior repeated D-amphetamine. Neuroscience 90:119-130.
58. Heimer L, Zahm DS, Alheid GF (1995). Basal ganglia. In: Paxinos G (editor): The Rat Nervous System. 2nd ed. San Diego: Academic Press; pp. 689-704.
59. Hennessy JW, Levin R, Levine S (1977). Influence of experiential factors and gonadal hormones on pituitary-adrenal response of the mouse to novelty and electric shock. J Comp Physiol Psychol 91:770-777.
60. Herman JP, Cullinan WE (1997). Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20:78-84.
61. Herman JP, Gulllonneau D, Dantzer R, Scatton B, Semerdjian-Rouquier L, Le Moal M (1982). Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat brain. Life Sci 30:2207-2214.
62. Hinson RE, Poulos CX (1981). Sensitization to the behavioral effects of cocaine: modification by Pavlovian conditioning. Pharmacol Biochem Behav 15: 559-562.
63. Horger BA, Shelton K, Schenk S (1990). Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol Biochem Behav 37:707-711.
64. Hori K, Tanaka J, Nimura M (1993). Effects of discrimination learning on the rat dopamine release: a microdialysis study. Brain Res 621:296-300.
65. Horner CH (1993). Plasticity of the dendritic spine. Prog Neurobiol 41:281-321.
66. Hughes P, Dragunow M (1995). Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev 47:133-178.
67. Hyman SE, Malenka RC (2001). Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2:695-703.
68. Jaeger TV, van der Kooy D (1993). Morphine acts in the parabrachial nucleus, a pontine viscerosensory relay, to produce discriminative stimulus effects. Psychopharmacology (Berl) 110:76-84.
69. Jaeger TV, van der Kooy D (1996). Separate neural substrates mediate the motivating and discriminative properties of morphine. Behav Neurosci 110:181-201.
70. Johansson B, Lindstrom K, Fredholm BB (1994). Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 59:837-849.
71. Johnson SW, North RA (1992). Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-488.
72. Kalivas PW, Stewart J (1991). Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16:223-244.
73. Kalivas PW, Duffy P, Latimer LG (1987). Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther 242:757-763.
74. Kelleher RT, Morse WH (1968). Determinants of the specificity of behavioral effects of drugs. Ergeb Physiol Chem Exp Pharmakol 60:1-56.
75. Kiyatkin EA (1992). State-dependent peculiarities of cocaine-induced behavioral sensitization and their possible reasons. Int J Neurosci 67:93-103.
76. Kolb B, Forgie M, Gibb R, Gorny G, Rowntree S (1998). Age, experience and the changing brain. Neurosci Biobehav Rev 22:143-159.
77. Kollack-Walker S, Watson SJ, Akil H (1997). Social stress in hamsters: defeat activates specific neurocircuits within the brain. J Neurosci 17:8842-8855.
78. Lê AD, Khanna JM (1989). Dispositional mechanisms in drug tolerance and sensitization. In: Goudie AJ, Emmett-Oglesby MW (editors): Psychoactive Drugs: Tolerance and Sensitization. Clifton, NJ: Humana Press; pp. 281-351.
79. Lee EHY, Tsai MJ (1989). The hyppocampus and the amygdala mediate the locomotor stimulating effects of corticotropin-releasing factor in mice. Behav Neural Biol 51:412-413.
80. Le Moal M (1995). Mesolimbic dopaminergic neurons: functional and regulatory roles. In: Bloom FE, Kupfer DJ (editors): Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; pp. 283-294.
81. Lett BT (1989). Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berl) 98:357-362.
82. Li Y, Kolb B, Robinson TE (2003). The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen. Neuropsychopharmacology 28:1082-1085.
83. Liang KC, Lee EHY (1988). Intra-amygdala injections of corticotropin-releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats. Psychopharmacology (Berl) 96:232-236.
84. Mendrek A, Blaha CD, Phillips AG (1998). Pre-exposure of rats to amphetamine sensitizes self-administration of this drug under a progressive ratio schedule. Psychopharmacology (Berl) 135:416-422.
85. Morgan MJ, Franklin KB (1990). 6-Hydroxydopamine lesions of the ventral tegmentum abolish D-amphetamine and morphine analgesia in the formalin test but not in the tail flick test. Brain Res 519:144-149.
86. Morimoto A, Nakamori T, Morimoto K, Tan N, Murakami N (1993). The central role of corticotrophin-releasing factor (CRF-41) in psychological stress in rats. J Physiol (Lond) 460:221-229.
87. Mucha RF, Iversen SD (1986). Increased food-intake after opioid microinjections into the nucleus accumbens and ventral tegmental area of rat. Brain Res 397:214-224.
88. Nestler EJ (2001). Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2:119-128.
89. Nielsen EB, Scheel-Kruger J (1986). Cueing effects of amphetamine and LSD: elicitation by direct microinjection of the drugs into the nucleus accumbens. Eur J Pharmacol 125:85-92.
90. Norrholm SD, Bibb JA, Nestler EJ, Ouimet CC, Taylor JR, Greengard P (2003). Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience 116:19-22.
91. Ostrander MM, Badiani A, Day HEW, Norton CS, Watson SJ, Akil H, Robinson TE (2003). Environmental context and drug history modulate amphetamine-induced c-fos mRNA expression in the basal ganglia, central extended amygdala, and associated limbic forebrain. Neuroscience 120:551-571.
92. Paolone G, Burdino R, Badiani A (2003). Dissociation in the modulatory effects of environmental novelty on the locomotor, analgesic, and eating response to acute and repeated morphine in the rat. Psychopharmacology (Berl) 166:146-155.
93. Paolone G, Palopoli M, Marrone MC, Nencini P, Badiani A (2004). Environmental modulation of the interoceptive effects of amphetamine in the rat. Behav Brain Res 152:149-155.
94. Papa M, Pellicano MP, Welzl H, Sadile AG (1993). Distributed changes in c-Fos and c-Jun immunoreactivity in the rat brain associated with arousal and habituation to novelty. Brain Res Bull 32:509-515.
95. Parthasarathy HB, Graybiel AM (1997). Cortically driven immediate-early gene expression reflects modular influence of sensorimotor cortex on identified striatal neurons in the squirrel monkey. J Neurosci 17: 2477-2491.
96. Paulson PE, Camp DM, Robinson TE (1991). Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology (Berl) 103:480-492.
97. Pert A, Sivit C (1977). Neuroanatomical focus for morphine and enkephalin-induced hypermotility. Nature 265:645-647.
98. Pert A, Post R, Weiss SR (1990). Conditioning as a critical determinant of sensitization induced by psychomotor stimulants. NIDA Res Monogr 97:208-241.
99. Pezzone MA, Lee WS, Hoffman GE, Rabin BS (1992). Induction of c-fos immunoreactivity in the rat forebrain by conditioned and unconditioned aversive stimuli. Brain Res 597:41-50.
100. Piazza PV, Deminiere JM, Le Moal M, Simon H (1989). Factors that predict individual vulnerability to amphetamine self-administration. Science 245:1511-1513.
101. Pierce RC, Bell K, Duffy P, Kalivas PW (1996). Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci 16:1550-1560.
102. Pitkanen A, Stefanacci L, Farb CR, Go G-G, LeDoux JE, Amaral DG (1995). Intrinsic connections of the rat amygdaloid complex: projections originating in the lateral nucleus. J Comp Neurol 356:288-310.
103. Plotsky PM, Cunningham ET Jr, Widmaier EP (1989). Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr Rev 10:437-458.
104. Post RM, Lockfeld A, Squillace KM, Contel NR (1981). Drug-environment interaction: context dependency of cocaine-induced behavioral sensitization. Life Sci 28:755-760.
105. Rescorla RA, Wagner AR (1972). A theory of Pavlovian conditioning: variations in the effectiveness of reinforcement and nonreinforcement. In: Black AH, Prokasy WF (editors): Classical Conditioning, II: Current Research and Theory. New York: Appleton-Century-Crofts; pp. 64-99.
106. Robbins TW, Everitt BJ (2002). Limbic-striatal memory systems and drug addiction. Neurobiol Learn Mem 78:625-636.
107. Robinson TE (1984). Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology (Berl) 84:466-475.
108. Robinson TE, Becker JB (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396:157-198.
109. Robinson TE, Berridge KC (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18:247-291.
110. Robinson TE, Berridge KC (2000). The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95(suppl 2):S91-S117.
111. Robinson TE, Berridge KC (2003). Addiction. Annu Rev Psychol 54:25-53.
112. Robinson TE, Kolb B (1997). Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17:8491-8497.
113. Robinson TE, Kolb B (1999a). Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse 33:160-162.
114. Robinson TE, Kolb B (1999b). Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci 11: 1598-1604.
115. Robinson TE, Kolb B (2004). Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology (in press).
116. Rosenkranz JA, Grace AA (2001). Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. J Neurosci 21:4090-4103.
117. Rosenkranz JA, Grace AA (2002). Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. J Neurosci 22:324-337.
118. Russell RL, Pihl RO (1978). The effect of dose, novelty, and exploration on amphetamine-produced stereotyped behavior. Psychopharmacology (Berl) 60:93-100.
119. Saper CB (1995). Central autonomic system. In: Paxinos G (editor): The Rat Nervous System. San Diego: Academic; pp. 107-135.
120. Sato M, Chen CC, Akiyama K, Otsuki S (1983). Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry 18:429-440.
121. Sato M, Numachi Y, Hamamura T (1992). Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 18:115-122.
122. Sax KW, Strakowski SM (2001). Behavioral sensitization in humans. J Addict Dis 20:55-65.
123. Segal DS, Kuczenski R (1994). Behavioral pharmacology of amphetamine. In: Cho AK, Segal DS (editors): Amphetamine and its Analogs: Psychopharmacology, Toxicology, and Abuse. San Diego: Academic Press; pp. 115-150.
124. Seiden LS, Sabol KE, Ricaurte GA (1993). Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 33:639-677.
125. Sgambato V, Abo V, Rogard M, Besson MJ, Deniau JM (1997). Effect of electrical stimulation of the cerebral cortex on the expression of the Fos protein in the basal ganglia. Neuroscience 81:93-112.
126. Shippenberg TS, Heidbreder C (1995). Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. J Pharmacol Exp Ther 273:808-815.
127. Simpson LL (1975). Blood pressure and heart rate responses evoked by D-and L-amphetamine in the pithed rat preparation. J Pharmacol Exp Ther 193: 149-159.
128. Stewart J, Badiani A (1993). Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 4:289-312.
129. Strakowski SM, Sax KW, Setters MJ, Keck PE Jr (1996). Enhanced response to repeated D-amphetamine challenge: evidence for behavioral sensitization in humans. Biol Psychiatry 40:872-880.
130. Szechtman H, Talangbayan H, Eilam D (1993). Environmental and behavioral components of sensitization induced by the dopamine agonist quinpirole. Behav Pharmacol 4:405-410.
131. Szumlinski KK, Allan M, Talangbayan H, Tracey A, Szechtman H (1997). Locomotor sensitization to quinpirole: environment-modulated increase in efficacy and context-dependent increase in potency. Psychopharmacology (Berl) 134:193-200.
132. Tilson HA, Rech RA (1973). Conditioned drug effects and absence of tolerance to D-amphetamine induced motor activity. Pharmacol Biochem Behav 1: 149-153.
133. Ujike H, Takaki M, Kodama M, Kuroda S (2002). Gene expression related to synaptogenesis, neuritogenesis, and MAP kinase in behavioral sensitization to psychostimulants. Ann NY Acad Sci 965:55-67.
134. Uslaner J, Badiani A, Day HEW, Watson SJ, Akil H, Robinson TE (2001a). Environmental context modulates the ability of cocaine and amphetamine to induce c-fos mRNA expression in the neocortex, caudate nucleus, and nucleus accumbens. Brain Res 920:106-116.
135. Uslaner J, Badiani A, Norton CS, Day HEW, Watson SJ, Akil H, Robinson TE (2001b). Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context. Eur J Neurosci 13:1977-1983.
136. Uslaner JM, Crombag HS, Ferguson SM, Robinson TE (2003a). Cocaine-induced psychomotor activity is associated with its ability to induce c-fos mRNA expression in the subthalamic nucleus: effects of dose and repeated treatment. Eur J Neurosci 17:2180-2186.
137. Uslaner JM, Norton CS, Watson SJ, Akil H, Robinson TE (2003b). Amphetamine-induced c-fos mRNA expression in the caudate-putamen and subthalamic nucleus: interactions between dose, environment, and neuronal phenotype. J Neurochem 85:105-114.
138. Vanderschuren LJ, Kalivas PW (2000). Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 151:99-120.
139. Vezina P (2004). Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci Biobehav Rev 27:827-839.
140. Vezina P, Stewart J (1984). Conditioning and place-specific sensitization of increases in activity induced by morphine in the VTA. Pharmacol Biochem Behav 20:925-934.
141. White FJ, Kalivas PW (1998). Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 51:141-153.
142. Williams JL, Barber RG (1989). Effects of cat exposure and cat odors on subsequent amphetamine-induced stereotypy. Pharmacol Biochem Behav 36:375-380.
143. Wise RA, Bozarth MA (1987). A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492.
144. Wolf ME (1998). The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54:679-720.
145. Woolverton WL, Cervo L, Johanson CE (1984). Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys. Pharmacol Biochem Behav 21:737-741.
146. Zinberg NE (1984). Drug, Set, and Setting: The Basis for Controlled Intoxicant Use. New Haven: Yale University Press.